The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
1 Year | 5 Year | 5 Year Annualized | Since IPO | |
---|---|---|---|---|
GEVO | -25.84% | +123.85% | +17.49% | -100% |
S&P | +15.06% | +95.03% | +14.29% | +410% |
Gevo, Inc. is a renewable chemicals and next generation biofuels company, which focuses on the development and commercialization of renewable alternatives to petroleum-based products. It operates through the following segments: Gevo and Gevo Development and Agri-Energy. The Gevo segment focuses on the research and development activities related to the future production of isobutanol, including the development of the firm's proprietary biocatalysts, the production and sale of renewable jet and other fuels, the retrofit process, and the next generation of chemicals and biofuels that will be based on the company's isobutanol technology. The Gevo Development and Agri-Energy segment is currently responsible for the operation of its agri-energy facility and the production of ethanol, isobutanol, and related products. The company was founded by Christopher Michael Ryan, Matthew W. Peters, Peter Meinhold, and Frances Hamilton Arnold on June 9, 2005 and is headquartered in Englewood, CO.
Investors are connecting a couple of semirelated dots, though the timing of their conclusions is a little suspicious.
Gevo just inked a massive deal for renewable hydrocarbons.
Q2 2025 | YOY Change | |
---|---|---|
Revenue | $43.41M | 725.3% |
Gross Profit | $18.34M | 684.4% |
Gross Margin | 42.25% | 101.9% |
Market Cap | $316.22M | 140.2% |
Market Cap / Employee | $2.59M | 0.0% |
Employees | 122 | 18.4% |
Net Income | $2.73M | 113.0% |
EBITDA | $13.01M | 165.9% |
Currently no data to display
Currently no data to display.
Currently no data to display.
Q2 2025 | YOY Change | |
---|---|---|
Net Cash | $126.90M | -48.7% |
Accounts Receivable | $11.03M | 383.1% |
Inventory | 16.9 | 391.7% |
Q2 2025 | YOY Change | |
---|---|---|
Long Term Debt | $141.53M | 105.7% |
Short Term Debt | $29.78M | 1427.3% |
Q2 2025 | YOY Change | |
---|---|---|
Return On Assets | -8.84% | 2.6% |
Return On Invested Capital | -15.48% | 5.0% |
Q2 2025 | YOY Change | |
---|---|---|
Free Cash Flow | -$7.77M | 62.4% |
Operating Free Cash Flow | -$2.52M | 78.0% |
Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
---|---|---|---|---|---|
Price to Book | 0.77 | 0.99 | 0.57 | 0.67 | 173.24% |
Price to Sales | 25.04 | 29.55 | 6.40 | 3.90 | -46.86% |
Price to Tangible Book Value | 0.79 | 1.02 | 0.58 | 0.84 | 237.40% |
Enterprise Value to EBITDA | -11.53 | -43.95 | -37.57 | 27.88 | 1174.35% |
Return on Equity | -14.8% | -15.0% | -16.1% | -11.7% | -12.60% |
Total Debt | $70.84M | $70.62M | $171.37M | $171.32M | 142.07% |
GEVO earnings call for the period ending June 30, 2022.
GEVO earnings call for the period ending March 31, 2022.
GEVO earnings call for the period ending December 31, 2021.
GEVO earnings call for the period ending September 30, 2021.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.